← Back
$VKTX All transactions

Viking Therapeutics, Inc.

A

$ Value

$0

Shares

20,400

Price

$0

Filed

Jan 5

Insider

Name

FOEHR MATTHEW W

Title

CIK

0001237556

Roles

Director

Transaction Details

Transaction Date

2026-01-02

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

20,400

Footnotes

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $34.94 to $35.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. | Represents a restricted stock unit award ("RSU") of common stock under the Issuer's 2024 Equity Incentive Plan. All shares subject to the RSU shall vest on the one year anniversary of the grant date of the award.

Filing Info

Accession No.

0001193125-26-003109

Form Type

4

Issuer CIK

0001607678

FOEHR MATTHEW W's History

Date Ticker Type Value
2026-04-07 OABI M $0
2026-04-07 OABI $29K
2026-04-07 OABI M $0
2026-02-18 OABI M
2026-02-18 OABI $53K
2026-02-18 OABI M $0
2026-02-18 OABI A $0
2026-02-18 OABI A $0
2026-02-17 OABI $35K
2026-02-16 OABI M $0

Other Insiders at VKTX (90d)

Insider Bought Sold Last
Aubuchon Neil William
Chief Commercial Officer
$150K 2026-03-10